Get started
Author

Yoshiji Hantani

Observed names: Hantani, Yoshiji, Y. HANTANI, Y. Hantani
ORCID: 0000-0002-7010-2470
Observed ORCID: 0000-0002-7010-2470
OpenAlex ID: A5079901164
Identification and Characterization of a Novel Chemotype MEK Inhibitor Able to Alter the Phosphorylation State of MEK1/2
2012 · Takayuki Yoshida, Junya Kakegawa, et al. · Oncotarget · 62
PDF
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor
2023 · Kazuki Otake, Minoru Ubukata, et al. · ACS Medicinal Chemistry Letters · 29
PDF
New Class of Corticotropin-Releasing Factor (CRF) Antagonists: Small Peptides Having High Binding Affinity for CRF Receptor
2004 · Yasuki Yamada, Kenji Mizutani, et al. · Journal of Medicinal Chemistry · 29
Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction
2019 · Seiji Kawashita, Koichi Aoyagi, et al. · Bioorganic & Medicinal Chemistry Letters · 24
Identification of an Arginase II Inhibitor via RapidFire Mass Spectrometry Combined with Hydrophilic Interaction Chromatography
2018 · Wataru Asano, Yu Takahashi, et al. · SLAS DISCOVERY · 24
PDF
Functional characterizations of polyethylene terephthalate-degrading cutinase-like enzyme Cut190 mutants using bis(2-hydroxyethyl) terephthalate as the model substrate
2018 · Yoshiji Hantani, Hiroshi Imamura, et al. · AIMS Biophysics · 19
Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases
2021 · Tatsuo Akaki, Yuki Bessho, et al. · Bioorganic & Medicinal Chemistry · 18
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors
2024 · Kazuki Otake, Yoshinori Hara, et al. · Journal of Medicinal Chemistry · 12
Screening approaches for the identification of Nrf2-Keap1 protein-protein interaction inhibitors targeting hot spot residues
2023 · Wataru Asano, Rie Hantani, et al. · SLAS DISCOVERY · 11
PDF
Metal binding to cutinase-like enzyme from Saccharomonospora viridis AHK190 and its effects on enzyme activity and stability
2019 · Akane Senga, Yoshiji Hantani, et al. · The Journal of Biochemistry · 11
PolycyclicN‐hetero compounds.XLIII.Syntheses and properties of 2‐substituted 1‐acetoxy‐6‐acetyl‐5,6‐dihydro‐4H‐imidazo[1′,2′:1,6]‐pyrimido[5,4‐d][1]benzazepinesviaN‐(6,7‐dihydro‐5H‐pyrimido[5,4‐d]‐[1]benzazepin‐4‐yl)amino acids and their analogous mesoionic compounds, and their related compounds as a series of potential blood platelet aggregation inhibitors
1993 · Tomohisa Nagamatsu, Yoshiji Hantani, et al. · Journal of Heterocyclic Chemistry · 11
PolycyclicN‐heterocyclic compounds.XLI. Synthesis of 4‐substituted 6,7‐dihydro‐5H‐pyrimido[5,4‐d][1]benzazepines, 1,2,5,6‐tetrahydro‐4H‐imidazo[1′,2′:1,6]pyrimido[5,4‐d][1]benzazepines and their related compounds as a series of potential blood platelet aggregation inhibitors
1993 · Tomohisa Nagamatsu, Yoshiji Hantani, et al. · Journal of Heterocyclic Chemistry · 8
Fragment-Based Discovery of Novel VE-PTP Inhibitors Using Orthogonal Biophysical Techniques
2023 · Wataru Asano, Kenji Yamanaka, et al. · Biochemistry · 6
Assay Development and Screening for the Identification of Ganglioside GM3 Synthase Inhibitors
2020 · Kenji Yamanaka, Yu Takahashi, et al. · Biochemistry · 6
Identification of inactive conformation‐selective interleukin‐2‐inducible T‐cell kinase ( ITK ) inhibitors based on second‐harmonic generation
2018 · Yoshiji Hantani, Kiyosei Iio, et al. · FEBS Open Bio · 6
PDF
Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation
2019 · Rie Hantani, Saya Hanawa, et al. · SLAS DISCOVERY · 4
Transglycosylation Activity of Catalytic Domain Mutant of Endo-1,3-β-glucanase from Cellulosimicrobium cellulans
2018 · Yoshiji Hantani, Shoko Motoki, et al. · Protein and Peptide Letters · 4
PolycyclicN-Hetero Compounds. XLII: Convenient Syntheses of 6, 7-Dihydro-5H-pyrido[2,3-b]pyrimido[4,5-d]azepine as a Novel Polyheterocyclic Ring System and Its 4-Substituted Derivatives
1991 · Tomohisa Nagamatsu, Yoshiji Hantani, et al. · Synthesis · 4
SAR study of small molecule inhibitors of the programmed cell death‐1/programmed cell death‐ligand 1 interaction
2021 · Seiji Kawashita, Koichi Aoyagi, et al. · Chemical Biology & Drug Design · 3
Identification of AMPD2 allosteric inhibitors with novel mechanism of action by fragment merging approach
2026 · Kenji Yamanaka, Toru Uhara, et al. · SLAS DISCOVERY
PDF
Correction to “Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors”
2024 · Kazuki Otake, Yoshinori Hara, et al. · Journal of Medicinal Chemistry
CCDC 2239439: Experimental Crystal Structure Determination
2023 · Otake, Kazuki, Ubukata, Minoru, et al. · The Cambridge Structural Database
Role of Cys residues of C-terminal SH2 domain of phosphoinositide 3-kinase in its conformational stability and CD28-binding ability
2022 · Momoka Iiyama, Yoshiji Hantani, et al. · Chemical Thermodynamics and Thermal Analysis
PDF
Identification of Novel Phospholipid Transfer Protein Inhibitors by High-Throughput Screening
2019 · Rie Hantani, Yu Takahashi, et al. · SLAS DISCOVERY
ChemInform Abstract: Polycyclic N‐Hetero Compounds. Part 43. Syntheses and Properties of 2‐ Substituted 1‐Acetoxy‐6‐acetyl‐5,6‐dihydro‐4H‐imidazo(1′,2′:1,6) pyrimido(5,4‐d)(1)benzazepines via N‐(6,7‐Dihydro‐5H‐pyrimido(5,4‐d)(1) benzazepin‐4‐yl)amino Acids and Their Analogous Mesoionic Compounds, and Their Related Compounds as a Series of Potential Blood Platelet Aggregation Inhibitors.
1993 · T. NAGAMATSU, Y. HANTANI, et al. · ChemInform
Works count: 34
Citation count: 292
H-index: 11
I10-index: 11
Year
Topic
Type